search
Back to results

Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds

Primary Purpose

Burns, Wound Healing

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Procellera (Bioelectric Wound Dressing)
Opsite (Transparent Adhesive Dressing)
Sponsored by
Vomaris Innovations
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Burns focused on measuring Burns, Wounds and Injuries, Skin Grafts, Bioelectric, Grafting, skin

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Wounds resulting from skin graft
  • Split thickness wound
  • Wound size greater than 2x2 cm
  • Wounds must be ≥5 cm away from all other wounds
  • Participant agrees to participate in follow-up evaluation
  • Participant must be able to read and understand informed consent, and sign the informed consent

Exclusion Criteria:

  • Concurrent participation in another clinical trial that involves an investigational drug or device that would interfere with this study
  • Participant is to receive another topical antimicrobial agent other than the study dressing
  • Participant with sensitivity or adverse reactions to silver or zinc
  • Pregnancy or nursing an infant or child
  • Immunosuppression
  • Active or systemic infection
  • Peripheral vascular occlusive disease
  • Collagen vascular disease
  • Connective tissue disease
  • Participant undergoing active cancer chemotherapy
  • Chronic steroid use
  • Decision impairment

Sites / Locations

  • Blodgett Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Procellera Wound Dressing

Opsite Transparent Adhesive Dressing

Arm Description

Dressing indicated for partial and full-thickness wounds. Dressing changes every 5-7 days, more frequently if needed

Polyurethane film dressing. Dressing changes every 5-7 days, more frequently if needed

Outcomes

Primary Outcome Measures

To compare epithelialization over time

Secondary Outcome Measures

To compare patient reported perception of pain
To compare scarring

Full Information

First Posted
February 1, 2010
Last Updated
December 9, 2010
Sponsor
Vomaris Innovations
search

1. Study Identification

Unique Protocol Identification Number
NCT01061502
Brief Title
Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds
Official Title
Efficacy of the PROCELLERA Wound Dressing in the Healing of Skin Graft Donor Sites
Study Type
Interventional

2. Study Status

Record Verification Date
December 2010
Overall Recruitment Status
Completed
Study Start Date
September 2009 (undefined)
Primary Completion Date
November 2010 (Actual)
Study Completion Date
November 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Vomaris Innovations

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether the use of a bioelectric wound dressing is effective in the healing of skin graft donor site wounds.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Burns, Wound Healing
Keywords
Burns, Wounds and Injuries, Skin Grafts, Bioelectric, Grafting, skin

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
Outcomes Assessor
Allocation
Non-Randomized
Enrollment
17 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Procellera Wound Dressing
Arm Type
Experimental
Arm Description
Dressing indicated for partial and full-thickness wounds. Dressing changes every 5-7 days, more frequently if needed
Arm Title
Opsite Transparent Adhesive Dressing
Arm Type
Active Comparator
Arm Description
Polyurethane film dressing. Dressing changes every 5-7 days, more frequently if needed
Intervention Type
Device
Intervention Name(s)
Procellera (Bioelectric Wound Dressing)
Other Intervention Name(s)
Procellera, PROSIT, Procellera Wound Dressing, Procellera Device
Intervention Description
Dressing used on one-half of the donor graft site. Dressing changes every 5-7 days, more frequently if needed
Intervention Type
Device
Intervention Name(s)
Opsite (Transparent Adhesive Dressing)
Other Intervention Name(s)
Opsite Dressing
Intervention Description
Semi-occlusive wound dressing placed on one-half of the skin graft donor site. Dressing change every 5-7 days, more frequently if needed.
Primary Outcome Measure Information:
Title
To compare epithelialization over time
Time Frame
3 months
Secondary Outcome Measure Information:
Title
To compare patient reported perception of pain
Time Frame
3 months
Title
To compare scarring
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Wounds resulting from skin graft Split thickness wound Wound size greater than 2x2 cm Wounds must be ≥5 cm away from all other wounds Participant agrees to participate in follow-up evaluation Participant must be able to read and understand informed consent, and sign the informed consent Exclusion Criteria: Concurrent participation in another clinical trial that involves an investigational drug or device that would interfere with this study Participant is to receive another topical antimicrobial agent other than the study dressing Participant with sensitivity or adverse reactions to silver or zinc Pregnancy or nursing an infant or child Immunosuppression Active or systemic infection Peripheral vascular occlusive disease Collagen vascular disease Connective tissue disease Participant undergoing active cancer chemotherapy Chronic steroid use Decision impairment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrew L Blount, MD
Organizational Affiliation
Blodgett Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Richard Wilcox, MD
Organizational Affiliation
Blodgett Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Blodgett Hospital
City
Grand Rapids
State/Province
Michigan
ZIP/Postal Code
49503
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds

We'll reach out to this number within 24 hrs